157 related articles for article (PubMed ID: 15749274)
1. Surprise neuroprotective potential of beta-lactam antibiotics.
Senior K
Drug Discov Today; 2005 Mar; 10(5):300. PubMed ID: 15749274
[No Abstract] [Full Text] [Related]
2. Antibiotics that protect the brain.
Secko D
CMAJ; 2005 Feb; 172(4):467-8. PubMed ID: 15710934
[No Abstract] [Full Text] [Related]
3. Beta-lactam antibiotics: newer formulations and newer agents.
Martin SI; Kaye KM
Infect Dis Clin North Am; 2004 Sep; 18(3):603-19, ix. PubMed ID: 15308278
[TBL] [Abstract][Full Text] [Related]
4. Antibiotics acting as neuroprotectants via mechanisms independent of their anti-infective activities.
Stock ML; Fiedler KJ; Acharya S; Lange JK; Mlynarczyk GS; Anderson SJ; McCormack GR; Kanuri SH; Kondru NC; Brewer MT; Carlson SA
Neuropharmacology; 2013 Oct; 73():174-82. PubMed ID: 23748053
[TBL] [Abstract][Full Text] [Related]
5. Beta-lactam antibiotics are multipotent agents to combat neurological diseases.
Ji HF; Shen L; Zhang HY
Biochem Biophys Res Commun; 2005 Aug; 333(3):661-3. PubMed ID: 15907788
[TBL] [Abstract][Full Text] [Related]
6. Part V. Other beta-lactam antimicrobials.
Gibbs WJ; Cooper TW; Bronze MS; Greenfield RA
J Okla State Med Assoc; 2007 Jan; 100(1):23-5. PubMed ID: 17378498
[No Abstract] [Full Text] [Related]
7. Newer beta-lactam antibiotics: doripenem, ceftobiprole, ceftaroline, and cefepime.
Bazan JA; Martin SI; Kaye KM
Infect Dis Clin North Am; 2009 Dec; 23(4):983-96, ix. PubMed ID: 19909894
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of resistance to beta-lactams in some common Gram-negative bacteria causing nosocomial infections.
Suárez CJ; Lolans K; Villegas MV; Quinn JP
Expert Rev Anti Infect Ther; 2005 Dec; 3(6):915-22. PubMed ID: 16307504
[TBL] [Abstract][Full Text] [Related]
9. New career possibilities for certain antibiotics?
Eisenstein M
Lab Anim (NY); 2005 Feb; 34(2):10. PubMed ID: 15685178
[No Abstract] [Full Text] [Related]
10. Part II. Introduction to the beta-lactam antibiotics.
Cooper TW; Gibbs WJ; Bronze MS; Greenfield RA
J Okla State Med Assoc; 2006 Oct; 99(10):516-20. PubMed ID: 17125105
[No Abstract] [Full Text] [Related]
11. Are beta-lactams related to higher morbidity and mortality in urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli?
You JH; Kei HW; Lau WC; Wong KY; Marasinghe T; Lee N; Ip M
J Hosp Infect; 2008 Feb; 68(2):181-3. PubMed ID: 18194826
[No Abstract] [Full Text] [Related]
12. [Beta-lactam antibiotics].
Suárez C; Gudiol F
Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):116-29. PubMed ID: 19254642
[TBL] [Abstract][Full Text] [Related]
13. [Ertapenem].
Gobernado M; Acuña C
Rev Esp Quimioter; 2007 Sep; 20(3):277-99. PubMed ID: 18080025
[No Abstract] [Full Text] [Related]
14. Beta-lactam antibiotic resistance: a current structural perspective.
Wilke MS; Lovering AL; Strynadka NC
Curr Opin Microbiol; 2005 Oct; 8(5):525-33. PubMed ID: 16129657
[TBL] [Abstract][Full Text] [Related]
15. Breakpoints for extended-spectrum beta-lactamase-producing Enterobacteriacae: pharmacokinetic/pharmacodynamic considerations.
MacGowan A
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():166-8. PubMed ID: 18154541
[TBL] [Abstract][Full Text] [Related]
16. Involvement of O8-antigen in altering beta-lactam antibiotic susceptibilities in Escherichia coli.
Sarkar SK; Ghosh AS
FEMS Microbiol Lett; 2008 May; 282(1):59-64. PubMed ID: 18328080
[TBL] [Abstract][Full Text] [Related]
17. Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role.
Roberts JA; Paratz J; Paratz E; Krueger WA; Lipman J
Int J Antimicrob Agents; 2007 Jul; 30(1):11-8. PubMed ID: 17442541
[TBL] [Abstract][Full Text] [Related]
18. ILSMRs (intensifier of beta-lactam-susceptibility in methicillin-resistant Staphylococcus aureus) from Tara [Caesalpinia spinosa (Molina) Kuntze].
Kondo K; Takaishi Y; Shibata H; Higuti T
Phytomedicine; 2006 Feb; 13(3):209-12. PubMed ID: 16428032
[TBL] [Abstract][Full Text] [Related]
19. Comment on: The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials.
Baddour LM; Steckelberg JM; Wilson WR
J Antimicrob Chemother; 2006 Jun; 57(6):1255; author reply 1255-6. PubMed ID: 16549509
[No Abstract] [Full Text] [Related]
20. Cellular and molecular aspects of the action of beta-lactam antibiotics.
Vuye A
J Pharm Belg; 1980; 35(5):377-88. PubMed ID: 7005421
[No Abstract] [Full Text] [Related]
[Next] [New Search]
